Literature DB >> 8278039

Spread of blood in cerebrospinal fluid following craniotomy simulates spinal metastases.

S Cronqvist1, D Greitz, P Maeder.   

Abstract

Postoperative myelography with water-soluble contrast media was performed in 36 children with a diagnosis of posterior cranial fossa tumour. The myelograms were normal in 15. In 5 an intramedullary tumour was present and 3 of these had in addition subarachnoid changes as evidence of tumour spread. The remaining 16 patient had subarachnoid changes of a different character, mainly located in the posterior thoracic region and similar to those seen after subarachnoid haemorrhage. It is suggested that they represent adhesions caused by blood from the operation. The blood is assumed to be distributed by the large cerebrospinal fluid pulsations to the cervical and thoracic regions. It is important to recognise and differentiate subarachnoid changes due to tumour and to postoperative adhesions to avoid unnecessary radiotherapy to the spinal cord.

Entities:  

Mesh:

Year:  1993        PMID: 8278039     DOI: 10.1007/bf00588402

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  22 in total

1.  TUMORS OF THE POSTERIOR FOSSA IN CHILDHOOD AND ADOLESCENCE. THEIR DIAGNOSTIC AND RADIOTHERAPEUTIC PATTERNS.

Authors:  E J LIEBNER; J I PRETTO; M HOCHHAUSER; W KASSARABA
Journal:  Radiology       Date:  1964-02       Impact factor: 11.105

2.  Gd-DTPA-enhanced MR imaging of leptomeningeal spread of primary intracranial CNS tumor in children.

Authors:  D J Rippe; O B Boyko; H S Friedman; W J Oakes; S C Schold; G R DeLong; W J Meisler
Journal:  AJNR Am J Neuroradiol       Date:  1990 Mar-Apr       Impact factor: 3.825

3.  Computed tomography of disseminated meningeal and ependymal malignant neoplasms.

Authors:  G F Ascherl; S K Hilal; R Brisman
Journal:  Neurology       Date:  1981-05       Impact factor: 9.910

4.  On the pulsatile nature of intracranial and spinal CSF-circulation demonstrated by MR imaging.

Authors:  D Greitz; A Franck; B Nordell
Journal:  Acta Radiol       Date:  1993-07       Impact factor: 1.990

5.  Medulloblastoma and other primary malignant neuroectodermal tumors of the CNS. The effect of patients' age and extent of disease on prognosis.

Authors:  J C Allen; F Epstein
Journal:  J Neurosurg       Date:  1982-10       Impact factor: 5.115

6.  Blood as tracer for CSF circulation after subarachnoidal hemorrhage.

Authors:  T Jedrzejczak; K Ericson; G Bergstrand; G Edner; H von Holst
Journal:  Acta Radiol       Date:  1990-11       Impact factor: 1.990

7.  Comparison of myelography with CT follow-up versus gadolinium MRI for subarachnoid metastatic disease in children.

Authors:  E D Kramer; S Rafto; R J Packer; R A Zimmerman
Journal:  Neurology       Date:  1991-01       Impact factor: 9.910

8.  The value of surveillance testing in childhood brain tumors.

Authors:  L E Kun; B D'Souza; M Tefft
Journal:  Cancer       Date:  1985-10-01       Impact factor: 6.860

Review 9.  The cytopathology of cerebrospinal fluid. II. Metastatic cancer, meningeal carcinomatosis and primary central nervous system neoplasms.

Authors:  S H Bigner; W W Johnston
Journal:  Acta Cytol       Date:  1981 Sep-Oct       Impact factor: 2.319

10.  Complete myelographic evaluation of spinal metastases from medulloblastoma.

Authors:  R H Dorwart; W M Wara; D Norman; V A Levin
Journal:  Radiology       Date:  1981-05       Impact factor: 11.105

View more
  2 in total

Review 1.  The leptomeninges as a critical organ for normal CNS development and function: First patient and public involved systematic review of arachnoiditis (chronic meningitis).

Authors:  Carol S Palackdkharry; Stephanie Wottrich; Erin Dienes; Mohamad Bydon; Michael P Steinmetz; Vincent C Traynelis
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752

2.  Subdural enhancement on postoperative spinal MRI after resection of posterior cranial fossa tumours.

Authors:  M Warmuth-Metz; J Kühl; J Krauss; L Solymosi
Journal:  Neuroradiology       Date:  2004-02-26       Impact factor: 2.804

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.